Deutsche Bank AG NA O.N. (0H7D)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 27.77 |
|---|---|
| 52-week range | 19.68 – 35.84 |
| Return, 1 month / 3 months | −12.4% / −7.6% |
| Return, 1 year / 3 years | +0.0% / +216.9% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -28.9% |
| Average daily value traded | 67.73M EUR |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Deutsche Bank is a German financial services company based in Frankfurt. It provides retail banking to private individuals, corporate and transaction banking to businesses, and investment banking services such as advisory work, financing and trading to companies and institutional clients. The bank also offers asset management through its fund business. Its customers range from personal account holders and small firms to large corporations and investors, and it operates across Europe, the Americas, Asia and other regions through a network of branches and offices.
On this site Deutsche Bank AG NA O.N. appears as a stock on the London Exchange (UK), code 0H7D, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Deutsche Bank AG NA O.N. (0H7D) trades on the London Exchange in UK. It last closed at EUR 27.77 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,544 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it fell 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.5% | ||
| From 52-week high | -22.2% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.6% | ||
| 6-month return | 5.7% | ||
| 12-month return, skipping the last month | 14.2% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.9% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 67.73M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.4% |
|---|---|
| 1 month | −12.4% |
| 3 months | −7.6% |
| 6 months | +5.7% |
| 1 year | +0.0% |
| 3 years | +216.9% |
| 5 years | +175.8% |
Signals
| 50-day / 200-day average | 32.21 / 29.69 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | EUR 1.0000 |
| 23 May 2025 | EUR 0.6800 |
| 17 May 2024 | EUR 0.4500 |
| 18 May 2023 | EUR 0.3000 |
| 20 May 2022 | EUR 0.2000 |
| 24 May 2019 | EUR 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.